4132-52-9Relevant articles and documents
H2S-BASED THERAPEUTIC AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page/Page column 10, (2019/07/17)
The present invention concerns the field of neurodegenerative diseases, and in particular relates to compounds, pharmaceutical compositions and their uses in the protection of neuronal cells from inflammation and from oxidative stress in the early stage o
Synthesis and structure-activity relationships study of dithiolethiones as inducers of glutathione in the SH-SY5Y neuroblastoma cell line
Brown, Dennis A.,Betharia, Swati,Yen, Jui-Hung,Tran, Quang,Mistry, Hitesh,Smith, Kari
, p. 5829 - 5831 (2014/12/12)
Parkinson's disease is a neurodegenerative disorder that involves the degeneration of nigrostriatal dopaminergic neurons. Elevated levels of reactive oxygen species have been shown to deplete cellular levels of the ubiquitous antioxidant glutathione, lead